CSIMarket Company Name, Ticker, Customers, else..


Iqvia Holdings Inc   (NYSE: IQV)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Iqvia Holdings Inc

IQV's Fundamental analysis



Looking into Iqvia Holdings Inc growth rates, revenue grew by 2.46 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1684

Medical Laboratories industry recorded growth of revenues by 2.95 %

Iqvia Holdings Inc 's net profit decreased by -13.54 % in first quarter of 2025 year on year, to $249 millions.

• More on IQV's Growth


Iqvia Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 95.2 in trailing twelve-month period.
Company
21.6
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.82.
Medical Laboratories industry's Price to Sales ratio is at 2.29.


• More on IQV's Valuation
 
 Total Debt (Millions $) 14,330
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 221,386
 Net Income/Employee (TTM) $ 19,057
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -76.35

Iqvia Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 95.2 in trailing twelve-month period.
Company
21.6
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.82.
Medical Laboratories industry's Price to Sales ratio is at 2.29.

Iqvia Holdings Inc Price to Book Ratio is at 4.71 lower than Industry Avg. of 156.97. and higher than S&P 500 Avg. of 0.01

• More on IQV's Valuation

•  Market Capitalization (Millions $) 28,180
•  Shares Outstanding (Millions) 177
•  Employees 70,000
•  Revenues (TTM) (Millions $) 15,497
•  Net Income (TTM) (Millions $) 1,334
•  Cash Flow (TTM) (Millions $) 296
•  Capital Exp. (TTM) (Millions $) -599
•  Total Debt (Millions $) 14,330
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 221,386
•  Net Income/Employee(TTM) $ 19,057
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -76.35

•  Market Capitalization (Millions $) 28,180
•  Shares Outstanding (Millions) 177
•  Employees 70,000
•  Revenues (TTM) (Millions $) 15,497
•  Net Income (TTM) (Millions $) 1,334
•  Cash Flow (TTM) (Millions $) 296
•  Capital Exp. (TTM) (Millions $) -599


    IQV's Profitability Comparisons
Iqvia Holdings Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 12.95 % from 15.82 % in IV. Quarter.

Iqvia Holdings Inc net profit margin of 6.5 % is currently ranking no. 7 in Medical Laboratories industry, ranking no. 113 in Healthcare sector and number 1374 in S&P 500.


Profitability by Segment
Total 6.5 %



  Ratio
•   Capital Ratio (MRQ) 1.13
•  Total Debt to Equity (MRQ) 2.39
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.58
•  Inventory Turnover Ratio (TTM) -



Iqvia Holdings Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 12.95 % from 15.82 % in IV. Quarter.

Iqvia Holdings Inc net profit margin of 6.5 % is currently ranking no. 7 in Medical Laboratories industry, ranking no. 113 in Healthcare sector and number 1374 in S&P 500.

• More on IQV's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com